Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Testing effectiveness (Phase 2)Study completedNCT04380688
What this trial is testing

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

Who this might be right for
COVID-19
AstraZeneca 62
Large-scale testing (Phase 3)Study completedNCT04545060
What this trial is testing

VIR-7831 for the Early Treatment of COVID-19 in Outpatients

Who this might be right for
Covid19
Vir Biotechnology, Inc. 1,057
Testing effectiveness (Phase 2)WithdrawnNCT04536090
What this trial is testing

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

Who this might be right for
COVID-19
Institut de Recherches Cliniques de Montreal
Not applicableUnknownNCT04552340
What this trial is testing

Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.

Who this might be right for
Covid19
Istituto Clinico Humanitas 1,500
Not applicableStudy completedNCT04933929
What this trial is testing

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Gérond'if 34
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Testing effectiveness (Phase 2)Study completedNCT04914377
What this trial is testing

To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants

Who this might be right for
Covid19
Novatek Pharmaceuticals 55
Not applicableUnknownNCT04281693
What this trial is testing

A New Screening Strategy for 2019 Novel Coronavirus Infection

Who this might be right for
Novel Coronavirus Infection Pneumonia
Affiliated Hospital to Academy of Military Medical Sciences 230
Large-scale testing (Phase 3)UnknownNCT04261426
What this trial is testing

The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia

Who this might be right for
2019-nCoV
Peking Union Medical College Hospital 80
Not applicableEnded earlyNCT04261907
What this trial is testing

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

Who this might be right for
2019-nCoV
First Affiliated Hospital of Zhejiang University 6
Large-scale testing (Phase 3)Ended earlyNCT04389840
What this trial is testing

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Acute Lung InjurySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jazz Pharmaceuticals 27
Early research (Phase 1)UnknownNCT04375046
What this trial is testing

Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2

Who this might be right for
COVID-19
Kafrelsheikh University 24
Not applicableStudy completedNCT04755972
What this trial is testing

Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2

Who this might be right for
Corona Virus InfectionPneumonia, Ventilator-Associated
Clinical Hospital Center, Split 175
Large-scale testing (Phase 3)Ended earlyNCT04913675
What this trial is testing

Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.

Who this might be right for
Covid19
Vir Biotechnology, Inc. 1,065
Not applicableActive Not RecruitingNCT06923137
What this trial is testing

Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19

Who this might be right for
COVID-19 SARS-CoV-2 InfectionCOVID-19COVID-19 Infection+6 more
Pfizer 1
Early research (Phase 1)Study completedNCT04280224
What this trial is testing

NK Cells Treatment for COVID-19

Who this might be right for
Novel Coronavirus Pneumonia
Henan Medical University 2
Not applicableStudy completedNCT04602871
What this trial is testing

Early Detection of COVID-19 Using Breath Analysis - Feasibility Study

Who this might be right for
Covid19
Scentech Medical Technologies Ltd 54
Post-approval studies (Phase 4)UnknownNCT04263402
What this trial is testing

The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia

Who this might be right for
2019-nCoV Severe Pneumonia
Tongji Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04521309
What this trial is testing

SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Dow University of Health Sciences 50
Next Page